Recruiting

RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

ClinicalTrials.gov IDNCT06906302

PhaseNA

Enrollment172

SponsorBoston University

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Intimate Partner Violence (IPV)

About this study

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health. Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.

Interventions

Behavioral: RISE — RISE is personalized, trauma-informed, empowerment-oriented and variable-length, consisting of an initial 60-minute session and up to 7 additional 45-minute sessions (1-8 sessions total).
Behavioral: Advocacy-based ECAU — Advocacy-based ECAU is a single 60-minute trauma-informed counseling intervention that includes supportive education, validating and empathetic statements, safety planning, resource provision and referrals.

Primary outcomes

Self-efficacy (Baseline, 3 months, 6 months. 9 months, 12 months, 15 months)

Eligibility information

Inclusion Criteria: * patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC) * report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and * be able to provide informed consent including permission to have intervention sessions recorded Exclusion Criteria: * severe cognitive impairment, * suicide or homicide intent with a specific plan * untreated or unstable symptoms of mania or psychosis

Study locations

VA Boston Healthcare System, Boston, Massachusetts 02130 United States
VA Minneapolis Healthcare System, Minneapolis, Minnesota 55417 United States
VA Philadelphia Healthcare System, Philadelphia, Pennsylvania 19104 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.